Soheil Naderi

2.1k total citations
59 papers, 1.5k citations indexed

About

Soheil Naderi is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Soheil Naderi has authored 59 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 19 papers in Oncology and 13 papers in Neurology. Recurrent topics in Soheil Naderi's work include Cancer-related Molecular Pathways (14 papers), Cell death mechanisms and regulation (7 papers) and Retinoids in leukemia and cellular processes (6 papers). Soheil Naderi is often cited by papers focused on Cancer-related Molecular Pathways (14 papers), Cell death mechanisms and regulation (7 papers) and Retinoids in leukemia and cellular processes (6 papers). Soheil Naderi collaborates with scholars based in Norway, Iran and United States. Soheil Naderi's co-authors include Heidi Kiil Blomhoff, Jean Y. J. Wang, Kristine B. Gützkow, Hege Ugland, Philippe Collas, Irina C. Hunton, Karen E. Knudsen, James R. Feramisco, Zvjezdana Sever-Chroneos and Erik S. Knudsen and has published in prestigious journals such as Journal of Biological Chemistry, Blood and The Journal of Immunology.

In The Last Decade

Soheil Naderi

58 papers receiving 1.5k citations

Peers

Soheil Naderi
David J. Feith United States
Kwan‐Hyuck Baek South Korea
Jian Wu China
Yan Cui China
Parag P. Shah United States
Ranjini K. Sundaram United States
Soheil Naderi
Citations per year, relative to Soheil Naderi Soheil Naderi (= 1×) peers Antonio F. Santidrián

Countries citing papers authored by Soheil Naderi

Since Specialization
Citations

This map shows the geographic impact of Soheil Naderi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soheil Naderi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soheil Naderi more than expected).

Fields of papers citing papers by Soheil Naderi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soheil Naderi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soheil Naderi. The network helps show where Soheil Naderi may publish in the future.

Co-authorship network of co-authors of Soheil Naderi

This figure shows the co-authorship network connecting the top 25 collaborators of Soheil Naderi. A scholar is included among the top collaborators of Soheil Naderi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soheil Naderi. Soheil Naderi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shahjouei, Shima, Georgios Tsivgoulis, Soheil Naderi, et al.. (2021). SARS-CoV-2 Is a Culprit for Some, but Not All Acute Ischemic Strokes: A Report from the Multinational COVID-19 Stroke Study Group. Journal of Clinical Medicine. 10(5). 931–931. 13 indexed citations
2.
Naderi, Soheil. (2020). COVID-19 Infection Leading to Lethal Spondylodiscitis with Spinal Abscess. 6(3). 151–154. 4 indexed citations
3.
Naderi, Soheil, et al.. (2019). Inhibitors of AKT kinase increase LDL receptor mRNA expression by two different mechanisms. PLoS ONE. 14(6). e0218537–e0218537. 8 indexed citations
4.
Khoshnevisan, Alireza, Soheil Naderi, Sina Abdollahzade, et al.. (2014). Effects of atorvastatin on plasma matrix metalloproteinase-9 concentration after glial tumor resection; a randomized, double blind, placebo controlled trial. DARU Journal of Pharmaceutical Sciences. 22(1). 10–10. 7 indexed citations
5.
Naderi, Soheil, Farideh Nejat, Shima Shahjouei, & Mostafa El Khashab. (2012). Cranial Dermal Sinus: Presentation, Complications and Management. Pediatric Neurosurgery. 48(2). 86–92. 19 indexed citations
6.
Carlsen, Harald, et al.. (2011). Hyperactivation of NF-κB via the MEK signaling is indispensable for the inhibitory effect of cAMP on DNA damage-induced cell death. Molecular Cancer. 10(1). 45–45. 22 indexed citations
7.
Hofgaard, Peter O., Harald Hauglin, Soheil Naderi, et al.. (2011). Cyclic AMP induces apoptosis in multiple myeloma cells and inhibits tumor development in a mouse myeloma model. BMC Cancer. 11(1). 301–301. 33 indexed citations
8.
Oppegård, Camilla, Shinya Ohara, Toshio Iijima, et al.. (2010). Plantaricin A, a peptide pheromone produced by Lactobacillus plantarum, permeabilizes the cell membrane of both normal and cancerous lymphocytes and neuronal cells. Peptides. 31(7). 1237–1244. 33 indexed citations
9.
Naderi, Soheil, et al.. (2009). Isolation of Salmonella enteritidis using biochemical tests and diagnostic potential of SdfI amplified gene.. Research Journal of Biological Sciences. 4(6). 656–661. 4 indexed citations
10.
Ugland, Hege, Andrew C. Boquest, Soheil Naderi, Philippe Collas, & Heidi Kiil Blomhoff. (2008). cAMP-mediated Induction of Cyclin E Sensitizes Growth-arrested Adipose Stem Cells to DNA Damage–induced Apoptosis. Molecular Biology of the Cell. 19(12). 5082–5092. 28 indexed citations
11.
Moltzau, Lise Román, Maria K. Dahle, Bjørn Steen Skålhegg, et al.. (2008). EBV infection renders B cells resistant to growth inhibition via adenylyl cyclase. Cellular Signalling. 20(6). 1169–1178. 6 indexed citations
12.
Blomhoff, Heidi Kiil, et al.. (2005). Degradation of cyclin D3 independent of Thr-283 phosphorylation. Oncogene. 25(17). 2468–2476. 9 indexed citations
13.
Naderi, Soheil, et al.. (2005). cAMP-mediated Inhibition of DNA Replication and S Phase Progression: Involvement of Rb, p21Cip1, and PCNA. Molecular Biology of the Cell. 16(3). 1527–1542. 42 indexed citations
14.
Gützkow, Kristine B., Soheil Naderi, Knut Martin Torgersen, et al.. (2003). Cyclic AMP inhibits translation of cyclin D3 in T lymphocytes at the level of elongation by inducing eEF2-phosphorylation. Cellular Signalling. 15(9). 871–881. 26 indexed citations
15.
Engedal, Nikolai, et al.. (2002). Retinoic Acid Stimulates the Cell Cycle Machinery in Normal T Cells: Involvement of Retinoic Acid Receptor-Mediated IL-2 Secretion. The Journal of Immunology. 169(10). 5555–5563. 78 indexed citations
16.
Naderi, Soheil, et al.. (2000). cAMP-mediated growth inhibition of lymphoid cells in G1: rapid down-regulation of cyclin D3 at the level of translation. European Journal of Immunology. 30(6). 1757–1768. 36 indexed citations
17.
Naderi, Soheil, Rune Blomhoff, June H. Myklebust, et al.. (1999). Lovastatin Inhibits G1/S Transition of Normal Human B-Lymphocytes Independent of Apoptosis. Experimental Cell Research. 252(1). 144–153. 17 indexed citations
18.
Naderi, Soheil & Heidi Kiil Blomhoff. (1999). Mad1 expression in the absence of differentiation: Effect of cAMP on the B-lymphoid cell line Reh. Journal of Cellular Physiology. 178(1). 76–84. 5 indexed citations
19.
Myklebust, June H., Dag Josefsen, Heidi Kiil Blomhoff, et al.. (1999). Activation of the CAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression. Journal of Cellular Physiology. 180(1). 71–80. 68 indexed citations
20.
Lindqvist, Bjørn H. & Soheil Naderi. (1995). Peptide presentation by bacteriophage P4. FEMS Microbiology Reviews. 17(1-2). 33–39. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026